Objective: Metabolic interventions that promote glucose use during ischemia have been shown to protect the myocardium and improve functional recovery on reperfusion. In this study we evaluated if cardioprotection can be accomplished by inhibiting fatty acid uptake, which would be expected to increase glycolytic metabolism. Methods: Diisothiocyanostilbene sulfonic acid (DIDS), commonly used to inhibit Band-3 mediated anion exchanger, and has also been demonstrated to inhibit fatty acid transport in adipocytes, was used to inhibit fatty acid uptake prior to ischemia. Isolated rat hearts were perfused with buffer containing 5 mM glucose, 70 mU / l insulin, 0.4 mM palmitate, and 0.4 mM albumin, paced at 300 beats / min, and subjected to 50 min of low-flow ischemia followed by 60 min of reperfusion. Results: Ischemic injury, as assessed by creatine kinase release, was diminished in hearts perfused with DIDS (334672 in DIDS vs. 5656314 IU / g dry wt in controls, P,0.04). Increases in LVEDP during ischemia were attenuated (863 mmHg in DIDS vs. 15618 mmHg in controls, P,0.03) and the % recovery of LV function with reperfusion was enhanced in DIDS-treated hearts (78610% of baseline in DIDS vs. 62619% of baseline in controls, P,0.04). These beneficial effects of DIDS were associated with increased glucose metabolism and ATP content during ischemia and reperfusion. Furthermore, treatment with DIDS lowered the accumulation of long chain acyl carnitines. Conclusions: This study demonstrates that DIDS protects ischemic myocardium, and is associated with inhibition of fatty acid uptake, improved glucose metabolism, and enhanced functional recovery on reperfusion. The data presented here suggest a potential role for therapeutic agents that lower fatty acid uptake as a metabolic adjunct in the treatment of myocardial ischemia.
Introduction
studies have demonstrated that infusion of glucose-insulin-potassium, which decreases plasma fatty acid levels Recanalization therapies are effective in restoring blood and thereby increases glucose use, is beneficial in patients flow to ischemic myocardium and thereby salvaging suffering from myocardial infarction [1, 2] . jeopardized tissue. However, adjunctive therapy based on Previous experimental studies have demonstrated that metabolic modification may be additionally beneficial in failure of energy production appears to be critical in the management of myocardial ischemia. In fact, recent ischemic myocardium [3] [4] [5] [6] [7] [8] . With ischemia, production of reviews and editorials have called for a re-exploration of adenosine triphosphate (ATP) increasingly depends on the use of metabolic strategies for myocardial preservation glycolytic flux, which eventually ceases because of feedin patients with ischemic heart disease. Recent clinical back inhibition by hydrogen ions, lactate, and fatty acid metabolites [3, 4, 7, [9] [10] [11] . Several studies have shown that sustenance of glycolytic metabolism during ischemia can preserve metabolism [4, [12] [13] [14] [15] [16] [17] , delay contracture -a mg / kg). After deep anesthesia was achieved, hearts were hallmark of glycolytic failure and irreversible cell damage, rapidly excised, placed into iced saline, and retrogradely and improve salvage with reperfusion.
perfused at 378C in a non-recirculating mode through the Enhancement of glycolysis in the setting of low-flow aorta at a rate of 12.5 ml / min. Hearts were perfused with ischemia can be accomplished by many approaches. In modified Krebs-Henseleit buffer containing (in mM) NaCl addition to enhancement of glucose metabolism directly 118, KCl 4.7, CaCl 1.2, MgCl 1.2, NaHCO 25, glucose 2 2 3 with high glucose, stimulation of adenosine A receptors 5, palmitate 0.4, BSA 0.4, and 70 mU / l insulin. The 1 [18, 19] , certain agents such as dichloroacetate or concentrations of palmitate and albumin used in this study ranolazine [4, 13, 14, 20] and ischemic preconditioning were based on concentrations of fatty acids and albumin [4, 21] may elicit beneficial effects in a low-flow ischemia present in rat plasma. The perfusate was equilibrated with model, in part, by sustaining glycolysis.
a mixture of 95% O -5% CO , which maintained perfu- 2 2 An alternative approach to achieving the switch to sate PO .600 mmHg. All hearts were paced at 300 beats 2 glucose utilization is by inhibiting fatty acid uptake [4,22- [4] . Thus, theoretically, blockade of fatty acid heart rate, and coronary perfusion pressure were monitored uptake may enhance myocardial glucose use via the continuously on a four-channel Gould recorder. Randle cycle and thereby protect ischemic myocardium. Diisothiocyanostilbene sulfonic acid (DIDS) has been 2.2. Palmitate uptake in the presence of DIDS commonly used to inhibit Band-3 mediated anion channel. However, DIDS has also been shown to inhibit fatty acid
To determine the ability of DIDS to inhibit palmitate uptake in cell culture and to characterize fatty acid binding uptake, in a separate set of experiments, hearts were sites in fatty acid transport proteins [26] [27] [28] . Since studies perfused with DIDS (10 mM) under normoxic conditions. demonstrating DIDS as an inhibitor of fatty acid transporIn order to accurately monitor fatty acid uptake, after ter were performed using adipocytes, it is unclear if DIDS equilibration, hearts were subjected to perfusion with would inhibit fatty acid uptake in isolated perfused rat recirculating buffer (100 ml). The difference between the hearts. Therefore, our goal in this study was to investigate concentration of palmitate in the perfusate before and after if DIDS would inhibit myocardial fatty acid uptake in recirculation yields the amount of palmitate used by the isolated perfused hearts, limit ischemic damage and enheart. A similar set of studies was performed to measure hance the benefits of reperfusion.
palmitate uptake during reperfusion.
Measurement of glucose oxidation

Methods
To determine if DIDS alters glucose oxidation,
14
All studies were performed with the approval of the Cardiac function was monitored throughout the protocol. Total long chain fatty acid content of these BSA solutions All hearts were paced at 300 beats / min with the use of was measured by gas chromatography and determined to pacing electrodes placed on to the right atrium. Two be less than 0.02 mM.
groups of hearts were subjected to 50 min of low flow ischemia (flow reduced from 12.5 to 0.7 ml / min) and 60 2.1. Isolated perfused heart preparation min of reperfusion. Perfusate temperature was maintained at 378C at all times during the protocol (i.e. during Experiments were performed using an isovolumic isobaseline, ischemia, and reperfusion). After an equilibration lated heart preparation as published earlier [13, 14, 21] and period of 30 min, the control group (CON, n59) of hearts modified for the use in rat hearts. Rats were anesthetized were perfused with modified Krebs-Henseleit buffer using a mixture of ketamine (80 mg / kg) and xylazine (10 throughout ischemia and reperfusion. In the second group of hearts, after the equilibration period of 30 min, hearts 2.8. Statistical analysis treated with DIDS (n56) were perfused with modified Krebs-Henseleit buffer containing 10 mM DIDS starting Values are expressed as means6S.D. Significance of the 10 min prior to ischemia and continuing throughout differences was determined using the one-way analysis of ischemia and reperfusion.
variance for repeated measurements with additional postPerfusate and coronary venous effluent samples were hoc tests for differences. P-values less than 0.05 were analyzed for PO with an Instrumentation Laboratories IL considered statistically significant.
2 213 pH-blood gas analyzer. Myocardial oxygen consumption was determined as previously published [13, 14, 21] . Samples were also analyzed for creatine kinase and lactate.
Results
Mechanical function 2.5. Tissue lipid content
To determine if the fatty acid uptake inhibition by DIDS To determine the effect of DIDS on changes in fatty would protect ischemic myocardium, and improve funcacids, triacylglycerols, and phospholipids, tissue levels of tional recovery on reperfusion, hearts treated with DIDS each of these compounds were assayed in fast frozen were subjected to ischemia and reperfusion and compared myocardial samples homogenized in methanol-water (5:2) with results obtained in control hearts. LVDP was similar and extracted in chloroform and methanol. The organic in both groups under baseline conditions (Table 1) . phase fractions were evaporated under nitrogen and subReduction of perfusate flow resulted in cessation of LVDP jected to thin-layer chromatography in petroleum ether, in both groups. Reperfusion resulted in a greater LVDP diethyl ether, and acetic acid (97:52:3). Plates were recovery in DIDS-treated hearts compared to controls scrapped at locations indicated by cochromatography of (LVDP recovery was 78610% of baseline in DIDS-treated known standards.
hearts compared with 62619% of baseline in controls, P,0.04).
Long chain acylcarnitine (LCA)
LVEDP was similar in both groups at the start of ischemia. During ischemia, the rise in LVEDP, i.e. contracPrevious studies have suggested a link between accumuture, was attenuated in the hearts treated with DIDS lation of LCA and depressed contractile function. To compared to controls (P50.03). Reperfusion resulted in evaluate the effect of DIDS on intermediates of cellular much higher LVEDP in controls compared to hearts treated fatty acid metabolism, we analyzed tissue content of LCA with DIDS. after baseline, ischemia, and reperfusion. Briefly, hearts
Myocardial oxygen consumption was similar in both were frozen rapidly in Wollenberger clamps precooled in groups under baseline and reperfusion conditions, and was liquid nitrogen, homogenized, extracted in perchloric acid, unaffected by DIDS perfusion (Table 1) . and centrifuged. The pellet fraction containing LCA was separated. Carnitine was measured radioisotopically after 3.2. Palmitate uptake in the presence of DIDS hydrolysis with KOH to convert LCA to free carnitine [10, [31] [32] [33] .
To determine if DIDS lowers fatty acid uptake under baseline and reperfusion conditions, hearts were perfused 2.7. High energy phosphate content Creatine kinase release, a marker of ischemic injury, 3.3. Glucose oxidation measurements was measured during reperfusion in both groups of hearts. Hearts perfused with DIDS prior to ischemia demonstrated To determine if DIDS inhibition of fatty acid uptake a 45% reduction in creatine kinase release compared to would shift the heart to use more glucose, hearts were control hearts (Fig. 2) perfused with C-labeled glucose and the CO release 2 present only during reperfusion, the reduction in creatine was measured. Under baseline conditions, glucose oxidakinase release was less than 5%, suggesting that the tion rates were significantly higher in DIDS-treated hearts protective properties of DIDS occur prior to and during compared to control hearts (oxidation rates in nmol / min ischemia. per g dry wt were 7586391 in DIDS-treated vs. 319689.5 in control hearts, P,0.01, n56 in each group). Similar 3.6. High energy phosphates increases in glucose oxidation were also observed during reperfusion in DIDS perfused hearts with oxidation rates
As shown in Figs. 3 and 4, baseline levels of ATP and being 5626129 in DIDS versus 365693 nmol / min per g PCr were similar in controls and DIDS-treated hearts. At dry wt in control hearts, P,0.03, n56 in each group.
the end of ischemia, PCr levels were markedly lower in These data are indicative of either increased exogenous both groups of hearts. End-ischemic ATP levels were glucose use or redirection of glucose to the oxidative modestly higher in hearts perfused with DIDS compared to pathway in DIDS perfused hearts. the controls. ATP and PCr levels during reperfusion were greater in DIDS hearts compared to controls (P,0.03).
Tissue levels of fatty acids and triglycerides in ischemic hearts
3.7. Lactate efflux during ischemia Since it is difficult to measure fatty acid uptake under ischemic conditions due to low levels of perfusate flow, we Lactate efflux is a measure of anaerobic glycolysis in measured tissue levels of fatty acids and triglycerides to ischemic myocardium. As shown in Fig. 5 , lactate efflux reflect changes in fatty acid metabolism. DIDS-treated was markedly increased in both control and DIDS-treated ischemic hearts had significantly lower levels of fatty acids hearts at the onset of ischemia. However, after about 15 compared to untreated ischemic hearts (total fatty acids min of ischemia, lactate efflux was significantly reduced in content were 401636 nmol / g wet wt. in DIDS-treated control hearts while lactate efflux was maintained at a ischemic vs. 598621 nmol / g wet wt. in untreated ishigher level in hearts treated with DIDS. Total lactate chemic hearts, P,0.03). Similarly, the triglyceride content was significantly lower in DIDS-treated ischemic hearts , in control (n56) and DIDS (n56) perfused hearts at baseline, at the end of ischemia and at the end of reperfusion. DIDS was successful in maintaining higher levels of Fig. 6 . Long chain acylcarnitine (LCA) content, expressed as nmol / g wet PCr during reperfusion. *P,0.05 versus control hearts.
wt., in control (n56) and DIDS (n56) perfused hearts during ischemia and reperfusion. DIDS-treated hearts had lower LCA content than controls (*P,0.04 vs. control hearts).
release during ischemia was significantly higher in DIDS hearts than in control hearts (P,0.05).
Long chain acylcarnitine (LCA)
To evaluate if the cardioprotection afforded by DIDS was associated with reduction in LCA levels, we measured LCA levels in both groups of hearts. Compared with controls, DIDS lowered LCA levels under baseline, ischemic and reperfusion conditions (Fig. 6) . 
Discussion
DIDS (n56) perfused hearts at baseline and at the end of ischemia. DIDS was successful in maintaining higher levels of ATP during ischemia and reperfusion. *P,0.05 versus controls.
The data presented here demonstrate a novel role for DIDS in lowering fatty acid uptake, increasing glucose use, and protecting ischemic myocardium. Furthermore, it was also demonstrated that the cardioprotection afforded by DIDS perfusion is associated with lowering fatty acid uptake and LCA levels and associated with increases in lactate efflux and ATP. These data also provide evidence that altering fatty acid uptake can contribute to metabolic protection during low-flow ischemia.
DIDS and fatty acid uptake
Studies in heart and skeletal muscle have demonstrated the presence of three putative fatty acid transporters [35] . The plasma membrane fatty acid binding protein (FABPpm), glycosylated fatty acid translocase (FAT) - their roles in long chain fatty acid uptake were determined (*P,0.05 vs. control hearts). Continued lactate production during [35] . Luiken et al. [35] demonstrated that palmitate uptake ischemia is beneficial in that it represents continued anaerobic metabolism.
by vesicles from rat hearts correlated well with the at Pennsylvania State University on February 21, 2013 http://cardiovascres.oxfordjournals.org/ Downloaded from expression of FABPpm and FAT / CD36 and that inhibition genase and pyruvate carboxylase; and increasing the ratio of these transporters significantly lowered palmitate upof long-chain acyl-CoA to LCA, with diminution of LCA. take. In earlier studies it has been shown that DIDS binds Studies have shown that accumulation of LCA is toxic to irreversibly to FAT / CD36 and inhibits fatty acid uptake myocardium [10, 22, 23, [31] [32] [33] and that they induce ar- [27, 28] . It is likely that the decreased palmitate uptake rhythmias, inhibit contractile function perhaps by altering observed in this study in hearts perfused with DIDS could the activity of ATP translocase [3, 38] and decrease glybe due to the binding of DIDS to FAT / CD36. colytic flux [22, 23, 36] . Oxfenicine, originally developed as an anti hyperglycemic agent, increases myocardial glucose 4.2. Inhibition of fatty acid uptake and cardioprotection utilization and decreases accumulation of LCA [22] . In a rabbit model of diabetic cardiomyopathy, we demonstrated Switching of substrate utilization from fatty acid to in isolated perfused hearts that decreasing the amount of glucose confers direct benefit to ischemic myocardium. fatty acid perfusing the heart was associated with diReduction in fatty acid uptake and oxidation by inhibiting minished myocardial long-chain fatty acids and triacyl-CPT-I using etomoxir has been shown to relieve fatty acid glycerol and was accompanied by immediate improvement inhibition of PDH and increase glucose use [4, 36] . Similarin contractile function [39] , suggesting the utility of ly, the use of carnitine or propionyl carnitine has been approaches that decrease deleterious levels of myocyte demonstrated to protect ischemic myocardium by increasfatty acids in improving function. Previous studies by ing glucose metabolism and decreasing tissue long chain others have suggested the mechanism by which substances acyl carnitine content [9, 11, 30, 37] .
such as propionyl-carnitine or L-carnitine work may, in In this study, we demonstrated that inhibiting fatty acid fact, be via enhancement of glucose metabolism [11, 30] . uptake with DIDS prior to ischemia, increased glucose use, Inhibition of fatty acid uptake, attenuation of LCA levels, maintained lactate release and ATP during ischemia, increased lactate efflux, and maintenance of ATP by DIDS lowered creatine kinase release, and improved left venare consistent with the above findings. tricular function on reperfusion.
Limitations 4.3. DIDS and lactate efflux during ischemia
It was demonstrated in this study that protection afSince the availability of oxygen during flow regulated forded by DIDS was associated with beneficial changes in ischemia is reduced, the ability of the myocardium to fatty acid metabolism. However, it should be noted that produce energy from oxidation of fatty acids and carbohythere are other effects of DIDS that may also contribute to drates is greatly reduced [4, [6] [7] [8] . Anaerobic glycolysis the observed cardioprotection. DIDS is well known to becomes an important energy source in ischemic myocarinhibit the chloride-bicarbonate exchanger and thus indium.
fluence pH recovery on reperfusion [40, 41] . A study by Although glycolytic flux, as measured by lactate efflux, Meiltz et al. demonstrated that inhibition of the anion increases at the onset of ischemia, the increase is short exchanger with DIDS protects anoxic embryonic hearts lived. The flux after 50 min of ischemia was still greater against reperfusion-induced dysfunction [42] . Furthermore, than the initial flux, although it was lower than the Lui et al. showed that DIDS inhibits the cardiac sodium maximal flux in the early phase (Fig. 5 ). This decrease in channel, which could also lead to cardioprotection [43] . In glycolytic flux is likely due to feedback inhibition of this study we did not measure intracellular pH or cardiac accumulating products such as NADH, lactate and protons sodium channel activity in the presence of DIDS either [8] . In this study, glucose oxidation, lactate production and during ischemia or on reperfusion. The goal was to ATP levels were higher in hearts perfused with DIDS demonstrate the property of DIDS in lowering fatty acid compared to controls. Furthermore, inhibition of fatty acid uptake and thereby increasing glucose use during ischemia. uptake and increased lactate production during ischemia However, the influence of pH changes or inhibition of are consistent with DIDS switching the substrate utilization sodium channel as a factor in mediating beneficial proptowards glucose.
erties of DIDS cannot be ruled out. It should be noted that glucose oxidation does contribute 4.4. Influence of long chain acylcarnitine to energy production during ischemia, albeit at a reduced level [44] . Hence, the potential for contribution of glucose In addition to enhancement of glycolysis, prevention of oxidation towards energy production in ischemic DIDS myocardial accumulation of long-chain fatty acids may hearts cannot be ruled out. modify intermediary metabolism favorably by decreasing The data on cardioprotection by DIDS must be inter- 
